Imagion Biosystems Limited (IBX.AX)

AUD 0.01

(0.0%)

EBITDA Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual EBITDA in 2023 was -13.69 Million AUD , down -66.17% from previous year.
Imagion Biosystems Limited's latest quarterly EBITDA in 2024 Q2 was -269.15 Thousand AUD , down 0.0% from previous quarter.
Imagion Biosystems Limited reported an annual EBITDA of -9.48 Million AUD in 2022, down -54.86% from previous year.
Imagion Biosystems Limited reported an annual EBITDA of -5.89 Million AUD in 2021, down -12.39% from previous year.
Imagion Biosystems Limited reported a quarterly EBITDA of -269.15 Thousand AUD for 2024 Q1, up 96.15% from previous quarter.
Imagion Biosystems Limited reported a quarterly EBITDA of -6.64 Million AUD for 2023 Q2, down -100.0% from previous quarter.

Annual EBITDA Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual EBITDA of Imagion Biosystems Limited (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	-13.69 Million AUD	-66.17%
2022	-9.48 Million AUD	-54.86%
2021	-5.89 Million AUD	-12.39%
2020	-5.19 Million AUD	-52.28%
2019	-3.27 Million AUD	59.58%
2018	-8.11 Million AUD	-22.04%
2017	-6.65 Million AUD	-1120.8%
2016	-779.61 Thousand AUD	86.27%
2015	-3.96 Million AUD	-74.74%
2014	-2.27 Million AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-269.15 Thousand AUD	0.0%
2024 Q1	-269.15 Thousand AUD	96.15%
2023 Q2	-6.64 Million AUD	-100.0%
2023 Q4	-7.45 Million AUD	-280.23%
2023 FY	- AUD	-66.17%
2023 Q1	-3.32 Million AUD	43.38%
2023 Q3	-1.96 Million AUD	70.48%
2022 Q3	-1.86 Million AUD	63.78%
2022 Q2	-5.15 Million AUD	-100.0%
2022 FY	- AUD	-54.86%
2022 Q1	-2.57 Million AUD	40.78%
2022 Q4	-5.86 Million AUD	-213.89%
2021 Q2	-3.86 Million AUD	-516.34%
2021 FY	- AUD	-12.39%
2021 Q4	-4.35 Million AUD	-95.03%
2021 Q1	-627.4 Thousand AUD	64.47%
2021 Q3	-2.23 Million AUD	42.25%
2020 Q1	-708.52 Thousand AUD	50.44%
2020 FY	- AUD	-52.28%
2020 Q4	-1.76 Million AUD	-2.34%
2020 Q3	-1.72 Million AUD	-143.49%
2020 Q2	-708.52 Thousand AUD	0.0%
2019 FY	- AUD	59.58%
2019 Q4	-1.42 Million AUD	-1.7%
2019 Q3	-1.4 Million AUD	-670.37%
2019 Q2	-182.49 Thousand AUD	0.0%
2019 Q1	-182.49 Thousand AUD	93.03%
2018 Q1	-1.66 Million AUD	31.95%
2018 FY	- AUD	-22.04%
2018 Q4	-2.61 Million AUD	0.07%
2018 Q3	-2.62 Million AUD	-57.37%
2018 Q2	-1.66 Million AUD	0.0%
2017 Q3	-2.44 Million AUD	-178.19%
2017 FY	- AUD	-1120.8%
2017 Q2	-879.45 Thousand AUD	0.0%
2017 Q1	-879.45 Thousand AUD	47.12%
2017 Q4	-2.44 Million AUD	0.0%
2016 Q4	-1.66 Million AUD	0.0%
2016 Q1	- AUD	0.0%
2016 FY	- AUD	86.27%
2016 Q2	- AUD	0.0%
2015 Q4	- AUD	0.0%
2015 FY	- AUD	-74.74%
2014 FY	- AUD	0.0%

Peer EBITDA Comparison of Imagion Biosystems Limited

Name	EBITDA	EBITDA Difference
Australian Clinical Labs Limited	181.83 Million AUD	107.533%
BCAL Diagnostics Limited	-5.66 Million AUD	-141.702%
Genetic Signatures Limited	-20.33 Million AUD	32.654%
Genetic Technologies Limited	-11.43 Million AUD	-19.824%
Healius Limited	-298.09 Million AUD	95.405%
Integral Diagnostics Limited	12.33 Million AUD	211.049%
INOVIQ Ltd	-6.63 Million AUD	-106.483%
Microba Life Sciences Limited	-22.8 Million AUD	39.95%
Monash IVF Group Limited	13.02 Million AUD	205.158%
Rhythm Biosciences Limited	-6.79 Million AUD	-101.545%
Sonic Healthcare Limited	1.65 Billion AUD	100.825%